{"id":"W2154488022","doi":"10.1158/1078-0432.ccr-10-1869","title":"Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"National Cancer Institute","keywords":"Gefitinib; Tamoxifen; Medicine; Internal medicine; Breast cancer; Placebo; Oncology; Metastatic breast cancer; Cancer; Epidermal growth factor receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004436493,0.0003454167,0.001581318,0.0004962795,0.0001490347,0.00002382245,0.0002840496,0.0001100532,0.000930579],"category_scores_gemma":[0.0005759289,0.000212437,0.00009166516,0.001548803,0.001072644,0.0003245221,0.0001493975,0.001398504,0.00001267418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008296515,"about_ca_system_score_gemma":0.001219423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005320702,"about_ca_topic_score_gemma":0.004722929,"domain_scores_codex":[0.9939038,0.001915366,0.001109016,0.0008761091,0.001385785,0.0008099162],"domain_scores_gemma":[0.9961843,0.001534297,0.0003012376,0.0005018764,0.001127031,0.000351248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7565652,0.01397453,0.1697223,0.0000515158,0.0004840563,0.0001235735,0.004356192,0.000007261037,0.00001354871,0.00002339111,0.00006166049,0.05461674],"study_design_scores_gemma":[0.6195373,0.01954836,0.3580247,0.0007307403,0.0001569466,0.000006041534,0.001442654,0.00006467284,0.00005096229,0.00011004,0.0000680138,0.0002595125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896954,0.0004983054,0.00006760738,0.0009855692,0.00008682843,0.008258254,0.0001610056,0.00004258957,0.0002044579],"genre_scores_gemma":[0.9938689,0.0003865495,0.0007393058,0.0001903079,0.0000983465,0.004195464,0.0000460652,0.00008356496,0.0003914992],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1883024,"threshold_uncertainty_score":0.9999827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1388367152218822,"score_gpt":0.4788527990782955,"score_spread":0.3400160838564134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}